Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: a Mixed Method Study
NCT ID: NCT06903390
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
96 participants
INTERVENTIONAL
2023-01-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions this study aims to answer are:
What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels.
Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care.
A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety.
This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care.
This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Masking Description:
Since this study involves a communication-based intervention, blinding is not feasible, as both participants and care providers are directly involved in delivering and receiving the intervention.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"QPL vs. standard care to assess impact on patient empowerment & anxiety in cancer patients.
Experimental Group 1 (QPL Communication Intervention Group) Participants in this group will receive a structured communication intervention using the Quick Question List (QPL) during their oncology examinations. The QPL aims to enhance patient empowerment, encourage active participation, and improve communication between patients and healthcare providers. It is designed to help patients express their concerns effectively and engage more actively in their care process.
Intervention:
Implementation of a QPL-based communication strategy in addition to standard oncology care.
QPL-based Communication Intervention
This QPL-based communication intervention stands out with the following key features:
Patient-Centered \& Cancer-Specific QPL: The intervention uses a QPL tailored for cancer patients, culturally adapted to enhance empowerment and manage anxiety.
Structured Training \& Support: Patients receive training before consultations, with additional guidance for effective QPL use at subsequent visits.
Multiple Assessment Points: The QPL's impact is measured after the first, second, and third consultations, allowing for longitudinal evaluation.
RCT Design: This study is a randomized controlled trial (RCT), comparing the intervention group (QPL) to a control group receiving standard care.
Focus on Empowerment \& Anxiety: Unlike prior studies, this intervention focuses on empowering patients and reducing anxiety, with outcomes measured through validated scales (Patient Empowerment Scale and HADS).
These features differentiate this intervention by offering a structured, culturally relevant approach.
Standard Care Group
Participants in this group will receive standard physician-patient communication without any additional intervention. This group serves as a control group to evaluate the effectiveness of the QPL-based communication intervention.
Intervention:
No additional communication tools or interventions will be applied. Patients will receive routine oncology consultations with standard physician-patient interactions.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QPL-based Communication Intervention
This QPL-based communication intervention stands out with the following key features:
Patient-Centered \& Cancer-Specific QPL: The intervention uses a QPL tailored for cancer patients, culturally adapted to enhance empowerment and manage anxiety.
Structured Training \& Support: Patients receive training before consultations, with additional guidance for effective QPL use at subsequent visits.
Multiple Assessment Points: The QPL's impact is measured after the first, second, and third consultations, allowing for longitudinal evaluation.
RCT Design: This study is a randomized controlled trial (RCT), comparing the intervention group (QPL) to a control group receiving standard care.
Focus on Empowerment \& Anxiety: Unlike prior studies, this intervention focuses on empowering patients and reducing anxiety, with outcomes measured through validated scales (Patient Empowerment Scale and HADS).
These features differentiate this intervention by offering a structured, culturally relevant approach.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must understand and speak Turkish.
* Must not have any condition preventing participation (e.g., advanced dementia, cognitive impairment, speech or hearing disorders).
* For healthcare professionals in the qualitative phase: Must have at least one year of experience in oncology.
Exclusion Criteria
* Patients with severe cognitive or physiological deterioration affecting participation.
* Patients who do not comply with the study process and requirements.
* Patients who voluntarily request to withdraw from the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asuman Kuscu
PhD Student, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marmara Üniversitesi
Istanbul, Kadıköy, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09.2022.953
Identifier Type: -
Identifier Source: org_study_id